Ovation Science Inc Ordinary Shares OVATF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OVATF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.04
- Day Range
- $0.04–0.04
- 52-Week Range
- $0.00–0.12
- Bid/Ask
- $0.03 / $0.04
- Market Cap
- $1.06 Mil
- Volume/Avg
- 11,500 / 5,195
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 17.34
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Ovation Science Inc is a Canada-based company mainly engaged in the business of sub-licensing rights to use Invisicare, a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products. The company also holds the right to manufacture, distribute, sell, market, sub-license and promote products formulated with Invisicare and containing cannabis products including cannabinoids, hemp seed oil and any synthetic derivatives of cannabis. It also develops formulas for skin product lines including topical and transdermal creams and lotions containing hemp seed oil and cannabis.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.ovationscience.com
Valuation
|
Metric
|
OVATF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 17.34 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
OVATF
|
|---|---|
Quick Ratio | 0.13 |
Current Ratio | 0.22 |
Interest Coverage | −82.13 |
Quick Ratio
OVATF
Profitability
|
Metric
|
OVATF
|
|---|---|
Return on Assets (Normalized) | −574.81% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
OVATF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Fdxnbqnwh | Vplpbs | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Zdnbhvdbrj | Wsxm | $68.9 Bil | |
HLN
| Haleon PLC ADR | Fwfnghrqd | Zprc | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Lysgxdjl | Zrtj | $14.7 Bil | |
VTRS
| Viatris Inc | Fqjxvcbn | Syxp | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Glhwxfs | Gkkb | $11.9 Bil | |
CTLT
| Catalent Inc | Cbzryrh | Dvwvdw | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Pxthwnq | Wxwc | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Vnprkhq | Tzvj | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ppfbrmc | Kqdfm | $3.5 Bil |